Loading
Amir Ali Talasaz takes a $1 salary, but Guardant Health, Inc.'s DEF 14A reports $8.7M in total compensation for FY2025. The largest component was $8.6M in stock awards. Most of the gap was $8.6M in stock awards. That’s down 25% from FY2024. Source: SEC DEF 14A.
In fiscal year 2025, Amir Ali Talasaz, Co-Chief Executive Officer of Guardant Health, Inc. (GH), received total compensation of $8.7 million.
Amir Ali Talasaz's compensation breakdown includes: base salary of $1, stock awards valued at $8.6 million, and other compensation of $14K.
Compared to fiscal year 2024, Amir Ali Talasaz's total compensation decreased 25% from $11.6 million to $8.7 million.
Guardant Health, Inc.'s top 6 named executive officers received combined total compensation of $30.7 million in fiscal year 2025.
The named executive officers disclosed in Guardant Health, Inc.'s 2025 proxy statement are:Amir Ali Talasaz (Co-Chief Executive Officer) with total compensation of $8.7 million, Helmy Eltoukhy (Chairman and Co-Chief Executive Officer) with total compensation of $8.7 million, Michael Bell (Chief Financial Officer) with total compensation of $3.8 million, Darya Chudova (Chief Technology Officer) with total compensation of $3.5 million, John Saia (Chief Legal Officer) with total compensation of $3.2 million, and Craig Eagle (Chief Medical Officer) with total compensation of $3.0 million.
Amir Ali Talasaz, Co-Chief Executive Officer of Guardant Health, Inc. (GH), received $8,661,227 in total compensation for FY2025, down 25.4% from the prior year. Stock awards of $8,647,709 were the largest component. Figures come from Guardant Health, Inc.'s DEF 14A 0001193125-26-187403 filed 28 Apr 2026.
Source Filing
Executive Record
Amir Ali Talasaz
Co-Chief Executive Officer
Reported Pay
$8.7MSummary compensation table total · FY2025
Findings
Reviewing FY2025 compensation of $8.7M against +234% shareholder return and the latest filing-backed pay disclosures.
Reported pay changed -25%; spread versus stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for GH.
Guardant Health, Inc. (GH) — Key Facts
Last updated Aug 26, 2026 · DEF 14A filed Apr 28, 2026
| CEO | Amir Ali Talasaz, Co-Chief Executive Officer |
|---|---|
| Fiscal year | FY2025 |
| Total compensation | $8.7M |
| Base salary | $1 |
| Stock awards | $8.6M |
| Other compensation | $14K |
| Year-over-year change | -25% |
| Source | DEF 14A, 2026-04-28 |
Amir Ali Talasaz's base salary at Guardant Health, Inc. was $1. Total compensation was $8,661,227 in fiscal year 2025. Most of the gap was $8,647,709 in stock awards. Figures come from Guardant Health, Inc.'s DEF 14A 0001193125-26-187403 filed 28 Apr 2026.
Amir Ali Talasaz's base salary at Guardant Health, Inc. is $1 per year as of fiscal year 2025. The larger reported compensation figure of $8,661,227 is mostly $8,647,709 in stock awards. Figures come from Guardant Health, Inc.'s DEF 14A 0001193125-26-187403 filed 28 Apr 2026.
Guardant Health, Inc.'s CEO, Amir Ali Talasaz, earned $8,661,227 in total compensation for fiscal year 2025. Base salary was $1, and most of the remaining total was $8,647,709 in stock awards. Figures come from Guardant Health, Inc.'s DEF 14A 0001193125-26-187403 filed 28 Apr 2026.
Reading filings for GH...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans